loader
Please Wait
Applying Filters...

What is Route Evaluation & Development? A CDMO that can optimize your API synthesis process early during technology transfer will reduce the risk of project delay or failure. That will also help your molecule run more efficiently in their plant. And time is money. Most medicinal chemists design novel active pharmaceutical ingredients (APIs) to secure a patent and IP protection, not to create a scalable production process. That makes sense. They are racing against the clock, running through fail

Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1EUROAPI

02 1Aspen API

03 1PMC Isochem

04 1Aesica Pharmaceuticals Limited

05 1Bellen Chemistry

06 1Bioindustria L.I.M. Spa

07 1Biolink LifeSciences

08 1CARBOGEN AMCIS AG

09 1Cambrex Corporation

10 1Clearsynth Labs Limited

11 1Curia

12 1Eurofins CDMO

13 1Evotec

14 1M2i Group

15 1Nanjing Dorra Pharmaceutical Technology Co.,Ltd

16 1POLYPHARMA TECH & SCIENCES

17 1Prague Scientific

18 1Siegfried AG

19 1UQUIFA

filter clear-filterReset all filters

PharmaCompass